Abstract:Objective To analyze the factors affecting the efficacy of nerve block therapy in elderly patients with postherpetic neuralgia (PHN). Methods A total of 140 elderly PHN patients who received nerve block therapy at the First Affiliated Hospital of Nanjing Medical University from December 2022 to January 2024 were selected as the study subjects. The patients′ general clinical data and treatment-related information were collected. Patients were followed up for 6 months after treatment, and treatment efficacy was statistically assessed through outpatient return visits and telephone follow-ups. According to the therapeutic effect, patients were divided into a good outcome group (n=99) and a poor outcome group (n=41). The factors affecting the efficacy of nerve block therapy in elderly PHN patients were analyzed by a logistic regression model, and the quality of life of the two groups was compared by the short-form-36 health survey (SF-36). SPSS 22.0 was used for data analysis. According to the data type, t test or Chi-square test was employed. Results After 6 months of follow-up, 99 (70.71%) among 140 patients had a decrease of ≥ 50% in visual analogue scale (VAS) from the baseline and were included in the good outcome group, and the remaining 41 (29.29%) had a VAS score decrease of <50% from the baseline and were included in the poor outcome group. Using treatment outcome as the dependent variable, logistic multi-variate analysis showed that diabetes mellitus (OR=3.357,95%CI 1.351-7.767), PHN duration ≥ 3 months (OR=2.863, 95%CI 1.092-7.511), and baseline VAS score ≥ 7 (OR=4.840,95%CI 1.781-13.152) were independent risk factors affecting the efficacy of nerve block therapy in elderly PHN patients, and that antiviral treatment during the acute phase of herpes zoster (HZ) (OR=0.375,95%CI 0.193-0.728) and maintenance of oral medication for two weeks after PHN pain relief (OR=0.484,95%CI 0.262-0.894) were protective factors (P<0.05). The total SF-36 score in the good outcome group were higher than those in the poor outcome group (P<0.05). Conclusion The efficacy of nerve block therapy for elderly PHN patients is related to the presence of diabetes mellitus, PHN duration, initial pain intensity, administration of antiviral treatment during the acute phase of HZ, and maintenance of oral medication after PHN pain relief, and poor treatment outcome reduces patients′ quality of life.